| Bioactivity | Lepzacitinib is a Janus kinase inhibitor targeting to JAK 1/3. Lepzacitinib exhibits anti-inflammatory effect and inhibits atopic dermatitis and other skin diseases[1]. |
| Target | JAK 1/3 |
| Name | Lepzacitinib |
| CAS | 2321488-47-3 |
| Formula | C18H21N5O3 |
| Molar Mass | 355.39 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Anderson, et al. Preparation of substituted pyrrolopyridine compounds as JAK inhibitors. World Intellectual Property Organization, WO2019090158 A1 2019-05-09. |
Lepzacitinib
CAS: 2321488-47-3 F: C18H21N5O3 W: 355.39
Lepzacitinib is a Janus kinase inhibitor targeting to JAK 1/3. Lepzacitinib exhibits anti-inflammatory effect and inhibi
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.